Pfm Health Sciences, LP Catalent, Inc. Transaction History

Pfm Health Sciences, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $3.29 Million - $4.3 Million	-37,730 Reduced 14.73%	218,366 $23.4 Million
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $6.65 Million - $8.79 Million	-70,604 Reduced 21.61%	256,096 $28.4 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $17.8 Million - $20.7 Million	148,900 Added 83.75%	326,700 $41.8 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $19.4 Million - $25.3 Million	177,800 New	177,800 $23.7 Million
Q1 2020 May 15, 2020	SELL	$36.95 - $62.95 $11.7 Million - $20 Million	-316,962 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $37.2 Million - $44.7 Million	-789,811 Reduced 71.36%	316,962 $17.8 Million
Q3 2019 Nov 14, 2019	BUY	$47.45 - $58.05 $23.2 Million - $28.4 Million	489,754 Added 79.37%	1,106,773 $52.7 Million
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $24.2 Million - $33.4 Million	617,019 New	617,019 $33.4 Million

344

137M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.